Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up 1.00% Nasdaq Up 1.29%
Streaming
Ticker Tape: On

Cell Therapeutics, Inc. (CTIC)

-NasdaqCM
2.99 0.06(1.97%) Apr 16, 4:00PM EDT
Get the big picture on all your investments.
Prev Close:3.05
Open:3.07
Bid:3.03 x 5500
Ask:3.07 x 5000
1y Target Est:5.38
Beta:1.51
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:2.95 - 3.09
52wk Range:0.97 - 4.25
Volume:2,779,756
Avg Vol (3m):5,498,740
Market Cap:421.05M
P/E (ttm):N/A
EPS (ttm):-0.44
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CTICDown 1.97%421.05M
BMY81.04B
RHHBY122.84B
SNY136.49B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.39
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.47
Quarterly EPS Est (Mar-14) :-0.17
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cell Therapeutics, Inc., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is... View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback